Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1097/MD.0000000000008229 http://scihub22266oqcxt.onion/10.1097/MD.0000000000008229 C5662375!5662375!29049209     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Medicine+(Baltimore) 2017 ; 96 (42): ä Nephropedia Template TP {{tp|p=29049209|t=2017. Pravastatin for prevention of HELLP syndrome: A case report |pdf=|usr=}}{{29049209}} gab.com Text Pravastatin for prevention of HELLP syndrome: A case report JO: Medicine (Baltimore) http://www.kidney.de/pget.php?&tw=1&pmid=29049209 #FOAvip Rationale:: Pravastatin has emerged for prevention and treatment of preeclampsia; no reports are available on pravastatin and HELLP (hemolysis, elevated liver enzymes and low platelets) syndrome. Patient concerns:: The first pregnancy necessitated termination of pregnancy at gestational age (GA) 20+5 for HELLP. Intrauterine fetal death at GA 22+5 occurred in the second pregnancy, whilst on temporizing management of HELLP. Diagnoses:: Severe, recurrent early-onset HELLP syndrome. Interventions:: In her fourth pregnancy, pravastatin was commenced at GA 13. Outcomes:: The course of pregnancy was uncomplicated, and a healthy, appropriate for gestational age fetus was delivered at term. Lessons:: Pravastatin may be effective in prevention of HELLP. The hepatic uptake may be of particular advantage. Twit Text FOAVip Pravastatin for prevention of HELLP syndrome: A case report ????Medicine (Baltimore) http://www.kidney.de/pget.php?&tw=1&pmid=29049209 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29049209 #FOAvip English Wikipedia <ref>{{Cite pmid|29049209}}</ref> Pravastatin for prevention of HELLP syndrome: A case report #MMPMID29049209 Otten LA; van der Ven K; Kühr M; Gembruch U; Merz WM Medicine (Baltimore) 2017[Oct]; 96 (42): ä PMID29049209show ga Rationale:: Pravastatin has emerged for prevention and treatment of preeclampsia; no reports are available on pravastatin and HELLP (hemolysis, elevated liver enzymes and low platelets) syndrome. Patient concerns:: The first pregnancy necessitated termination of pregnancy at gestational age (GA) 20+5 for HELLP. Intrauterine fetal death at GA 22+5 occurred in the second pregnancy, whilst on temporizing management of HELLP. Diagnoses:: Severe, recurrent early-onset HELLP syndrome. Interventions:: In her fourth pregnancy, pravastatin was commenced at GA 13. Outcomes:: The course of pregnancy was uncomplicated, and a healthy, appropriate for gestational age fetus was delivered at term. Lessons:: Pravastatin may be effective in prevention of HELLP. The hepatic uptake may be of particular advantage. äPravastatin for prevention of HELLP syndrome: A case report (epmc).pdf DeepDyve Pubget Overpricing